NIKKEI 225
38,179.46 -49.65 (-0.13%) HANG SENG
19,115.06 +151.38 (+0.80%) CRUDE OIL
79.20 +0.94 (+1.20%) GOLD FUTURES
2,343.20 -31.80 (-1.34%) DOW
39,431.51 -81.33 (-0.21%) Bitcoin GBP
50,277.92 +1,412.02 (+2.89%)
XWELL, Inc. (XWEL)
| Previous close | 1.8600 |
| Open | 1.8500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.7800 - 1.9499 |
| 52-week range | 1.2600 - 6.4000 |
| Volume | |
| Avg. volume | 13,498 |
| Market cap | 7.739M |
| Beta (5Y monthly) | 2.39 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
XWELL Inc (XWEL) Q4 2023 Earnings Call Transcript Highlights: Strategic Expansions and Cost ...
Discover how XWELL Inc's innovative strategies and operational efficiencies are shaping its journey towards profitability and expansion.
- Insider Monkey
XWELL, Inc. (NASDAQ:XWEL) Q4 2023 Earnings Call Transcript
XWELL, Inc. (NASDAQ:XWEL) Q4 2023 Earnings Call Transcript April 16, 2024 XWELL, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to XWELL’s Fiscal Year 2023 Earnings Results Conference Call. During today’s presentation, all parties will be […]
- Reuters
US CDC to expand surveillance of travelers for respiratory viruses
The U.S. Centers for Disease Control and Prevention (CDC) will expand its traveler-based surveillance program to include testing for respiratory viruses, partners Ginkgo Bioworks and XWELL said on Monday. The expansion, to be launched at four of the seven participating airports, comes ahead of the fall and winter months in the United States when viruses that cause respiratory diseases such as influenza and respiratory synctial virus (RSV)usually circulate more heavily. CDC has warned that it expects hospitalizations from COVID-19, RSV infections and flu this year to be similar to last year's numbers, higher than the pre-pandemic levels.
